PROMOTION Registry | Fondazione Gimema
home,page,page-id-14869,page-template-default,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-7.8,wpb-js-composer js-comp-ver-4.8.1,vc_responsive

Patient-Reported Outcome Measurements Over Time IONcology

Patient-Reported Outcome Measurements Over Time In ONcology

Patient-Reported Outcome Measurements Over Time In ONcology

Patient-Reported Outcome Measurements Over Time In ONcology

About the PROMOTION Registry

The PROMOTION database is a registry of all cancer Randomized Controlled Trials (RCTs) with a Patient-Reported Outcome (PRO) endpoint published since 2004. The PROMOTION database now contains information on some 1,000 PRO-RCTs conducted across a wide range of cancer specialties that have enrolled half a million of patients (see database content)


This large international initiative, involving several key experts in quality of life and PRO research in oncology, started in April 2012 and it was initially supported in part by a research grant from the EORTC Quality of Life Group to the GIMEMA. The Project also relies on the guidance of experts, acting as Advisory Board members, and on an international network of dedicated Co-Investigators involved at different levels in the project, for example, identification of eligible studies for inclusion in the PROMOTION Registry, study evaluation, data collection and analyses.


The PROMOTION database contains several information regarding, for example, the PRO assessment methodology, the statistical design and the reported clinical and PRO results of RCTs. Such information is systematically collected and electronically archived into a password protected database. Typical data contained in the Registry are related, for example to: type of PRO instruments used, information regarding clinical significance of quality of life outcomes or details regarding the statistical approaches used to address missing quality of life data. A standardized working methodology is used and evaluation of studies that populate the database is performed using a common set of criteria across all cancer disease sites, thus allowing comparisons across all cancer areas.


Quality of life and other types of PROs are now frequently included as endpoints in cancer clinical trials. However, assessing PROs requires making a number of challenging decisions with regard to, for example, data collection, appropriate timing of assessment, adequate statistical analysis as well as outcome interpretation. Inadequate or poorly designed and reported PROs investigations in the context of RCTs, can mislead clinical decision making as it hampers a clear appraisal of the validity of the outcomes. Cancer patients, physicians and health policy makers should rely on the most solid evidence to make informed decisions. Therefore, providing the scientific community with high quality data in this area is of paramount importance.


The PROMOTION Registry was thus developed to be a source of information to possibly answer a number of research questions revolving around the use and the added value of PROs assessment in cancer research.



Principal Investigator, Fabio Efficace

Head, Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy; Adjunct Professor, Feinberg School of Medicine, Northwestern University, Chicago, USA.


Advisory Board

Neil K. Aaronson

Emeritus Senior Staff Scientist/Group Leader, Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute and Emeritus Professor, Department of Clinical Psychology, The University of Amsterdam, The Netherlands.

johannes tonda

Johannes Giesinger

Senior Researcher, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.


Rajshekhar Chakraborty

Assistant Professor, Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.


Amélie Anota

Statistician, Department of Statistics, Léon Bérard Cancer Center, Lyon, France.


David Cella

Professor and Chair, Department of Medical Social Sciences. Director, Institute for Public Health and Medicine (IPHAM) – Center for Patient-Centered Outcomes. Feinberg School of Medicine, Northwestern University, Chicago, USA


Francesco Cottone

Senior statistician, Health Outcomes Research Unit, GIMEMA
Statistical Advisor for the PROMOTION Registry


Francesco Cottone supports the PROMOTION team in the statistical analyses and preparation of statistical reports of data contained in the PROMOTION Registry database.

He also assists PROMOTION team members in making decisions about the most appropriate statistical methods to use to address a specific research question.


Francesco Sparano

Data manager, Health Outcomes Research Unit, GIMEMA
Project manager for the PROMOTION Registry

Francesco Sparano supports the Principal Investigator in all aspects of the project to ensure compliance with standard operating procedures and to ensure accuracy, completeness and proper usage of the PROMOTION Database. He is also responsible for checking data quality, coordinating the overall activities and communication amongst all collaborators from participating Institutions.